TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 127 filers reported holding TG THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,360,000 | -59.2% | 1,000,000 | +21.2% | 2.75% | -59.4% |
| Q2 2023 | $20,493,000 | +23.9% | 825,000 | -25.0% | 6.76% | +38.3% |
| Q1 2023 | $16,544,000 | +137.0% | 1,100,000 | +511.1% | 4.89% | +154.8% |
| Q2 2021 | $6,982,000 | -27.6% | 180,000 | -10.0% | 1.92% | -15.3% |
| Q1 2021 | $9,640,000 | -25.9% | 200,000 | -20.0% | 2.27% | -21.8% |
| Q4 2020 | $13,005,000 | +143.0% | 250,000 | +25.0% | 2.90% | +87.3% |
| Q3 2020 | $5,352,000 | -54.2% | 200,000 | -66.7% | 1.55% | -49.8% |
| Q2 2020 | $11,688,000 | +493.9% | 600,000 | +200.0% | 3.08% | +490.8% |
| Q1 2020 | $1,968,000 | +181.5% | 200,000 | +217.5% | 0.52% | +292.5% |
| Q4 2019 | $699,000 | +174.1% | 63,000 | +38.5% | 0.13% | +146.3% |
| Q3 2018 | $255,000 | -62.7% | 45,500 | -12.5% | 0.05% | -73.1% |
| Q2 2018 | $684,000 | -83.9% | 52,000 | -82.7% | 0.20% | -76.7% |
| Q1 2018 | $4,260,000 | – | 300,000 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |